Arixtra approved for new blood clot indication
July 20, 2005Sales and Marketing Arixtra, GlaxoSmithKline
GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …
Iressa successor enters phase III
July 19, 2005Research and Development, Sales and Marketing
AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
AstraZeneca invests in novel cholesterol drugs
July 15, 2005Research and Development
AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …
Getting inside the customer’s head
July 11, 2005Sales and Marketing
Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …
NHS tsar calls on clinicians to reassess clinical practice
July 11, 2005The NHS tsar for primary care has called on clinicians to challenge the way they undertake clinical practice in order …
‘Virtual super surgeries’ the future for primary care
July 8, 2005Plans to redesign the primary care landscape with the creation of purpose-built super surgeries are in many cases unfeasible, according …
GSK win for Euro RSCG Life MSC
July 7, 2005Medical Communications
GlaxoSmithKline has awarded the pan-European launch of a major new neurological product to Euro RSCG Life MSC, following a three-way …
ABPI sets up links to clinical trials databases
July 7, 2005Sales and Marketing
Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …
Pfizer pulls out of Daxas collaboration
July 7, 2005Sales and Marketing Daxas, Nycomed, Pfizer
Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
One Europe for pharma marketers?
July 6, 2005Sales and Marketing
Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …
No more Alton Towers? UK pharma downsizes its hospitality
July 6, 2005Sales and Marketing
UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …
Lilly buys rights to novel diabetes drug
July 6, 2005Research and Development, Sales and Marketing
Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
Antidepressants come under FDA review again
July 4, 2005Sales and Marketing
The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
GSK excited about new vaccines
July 4, 2005Sales and Marketing
GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
Doctors have no time to mentor nurse prescribers
June 30, 2005Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
